Overview


According to FutureWise analysis the market for medical plastics in 2023 is US$ 29.91 billion, and is expected to reach US$ 51.47 billion by 2031 at a CAGR of 7.02%.

Medical plastics are polymer materials used in the manufacture of medical devices and equipment, including implants, surgical instruments, diagnostic equipment, drug delivery devices, and others. These plastics are designed to meet specific requirements such as biocompatibility, sterilization, and chemical resistance, making them suitable for use in healthcare settings. Medical plastics have several advantages over traditional materials such as metals and ceramics. They are lightweight, cost-effective, and can be moulded into complex shapes and sizes, making them ideal for manufacturing medical devices and equipment. They also offer a high strength-to-weight ratio and excellent resistance to chemicals and wear, making them appropriate for uses that need exceptional endurance and durability.

There are different types of medical plastics available, including polyethylene, polypropylene, polycarbonate, polyvinyl chloride (PVC), and others. Each type of medical plastic has its unique properties and characteristics that make them suitable for specific applications in the healthcare industry. Polyethylene is a commonly used medical plastic that offers high strength, toughness, and durability, making it suitable for use in implants, orthopedic devices, and prosthetics. Polypropylene is another popular medical plastic that is used in the manufacture of syringes, IV bags, and other medical products due to its excellent chemical resistance and clarity. Polycarbonate is a medical plastic that offers high transparency, toughness, and biocompatibility, making it suitable for use in diagnostic equipment, face shields, and protective eyewear. PVC is a widely used medical plastic that offers excellent flexibility, clarity, and chemical resistance, making it suitable for use in medical tubing, blood bags, and other medical products.

FutureWise Market Research has published a report that provides an insightful analysis of Medical Plastic Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Medical Plastic Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Sabic
  • BASF
  • Celanese Corporation
  • Evonik
  • Solvay
  • Arkema
  • Covestro
  • Ensinger
  • Lubrizol
  • Trinseo
  • Biomerics
  • DSM
  • Eastman Chemical Company
  • E. I. Du Pont De Nemours and Company
  • Invibio
  • Lanxess
  • Londyllbasell
  • Mitsubishi Chemical Advanced Materials
  • Polyone
  • Röchling
  • Rtp Company
  • Saint Gobain Performance Plastics
  • Tekni Plex
  • Teknor Apex
  • Wacker Chemie

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Medical Plastic Market:

  • In July 2021, Pawling Engineered Products was acquired by Minnesota Rubber and Plastics. The purchase of - Pawling's expertise will enhance MRP's existing product lines, which includes medical device, engineered elastomer & thermoplastics, medical device, transportation, food and beverage, and other critical industries across the world.

The medical plastic market is a rapidly growing industry that is driven by various factors, such as increasing demand for medical devices and equipment, rising healthcare expenditure, and technological advancements in the field of plastic materials. Medical plastics are used in a wide range of applications, such as implants, drug delivery devices, surgical instruments, and diagnostic equipment. The increasing aging population, rising prevalence of chronic diseases, and growing awareness about healthcare have increased the demand for medical devices and equipment. As a result, there is now a higher need for medical plastics as they offer numerous advantages such as ease of processing, low cost, and high strength-to-weight ratio compared to other materials such as metals and ceramics. Another significant driver of the medical plastics market is the growing trend toward the development of more advanced medical devices and equipment. With the increasing need for more complex and precise devices, medical plastics are increasingly being used to provide superior performance and better patient outcomes. Moreover, the ongoing COVID-19 pandemic has also significantly impacted the medical plastics market dynamics. The pandemic has increased the demand for medical devices such as ventilators, face shields, and PPE kits, all of which rely heavily on medical plastics. This has further fueled the growth of the medical plastics market as manufacturers ramp up production to meet the growing demand.

However, the medical plastics market also faces several challenges, such as stringent regulations governing the use of medical plastics and increasing environmental concerns associated with plastic waste.

By Type

  • Engineering plastics
  • High performance plastics (HPP)
  • Standard plastics
  • Silicone
  • Others (TPE, TPU, Biodegradable Polymers, Synthetic Rubber, and Polymer Blends)

By Application

  • Medical disposables
  • Prosthetics
  • Medical instruments and tools
  • Drug delivery
  • Others (medical trays, sterilization trays, and lab wares)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The APAC region is predicted to expand significantly in the medical plastics market in the coming years. This is primarily due to the rising healthcare expenditure, increasing demand for medical devices and equipment, and the growing population in countries such as China and India. Additionally, the region's low labour costs and availability of raw materials have also attracted many global manufacturers to invest in the region. Due to the expansion of medical device production in China, India, and Japan, the Asia-Pacific region will likely dominate the market throughout the projected period. The demand for medical plastics may rise as a result of the medical tourism boom that South Korea has been experiencing. Thus, these elements are anticipated to influence the demand for medical plastics throughout the projected period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Medical Plastics Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Medical Plastics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Medical Plastics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Medical Plastics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Medical Plastics Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Engineering plastics
        2. High performance plastics (HPP)
        3. Standard plastics
        4. Silicone
        5. Others (TPE, TPU, Biodegradable Polymers, Synthetic Rubber, and Polymer Blends)

  • 8.   Medical Plastics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medical disposables
        2. Prosthetics
        3. Medical instruments and tools
        4. Drug delivery
        5. Others (medical trays, sterilization trays, and lab wares)

  • 9.   North America Medical Plastics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Medical Plastics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Medical Plastics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Medical Plastics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Sabic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BASF
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Celanese Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Evonik
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Solvay
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Arkema
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Covestro
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ensinger
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Lubrizol
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Trinseo
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Biomerics
         11.1. Company Overview
         11.2. Targeted Antigen Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. DSM
         12.1. Company Overview
         12.2. Targeted Antigen Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Eastman Chemical Company
         13.1. Company Overview
         13.2. Targeted Antigen Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. E. I. Du Pont De Nemours and Company
         14.1. Company Overview
         14.2. Targeted Antigen Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Invibio
         15.1. Company Overview
         15.2. Targeted Antigen Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Lanxess
         16.1. Company Overview
         16.2. Targeted Antigen Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Londyllbasell
         17.1. Company Overview
         17.2. Targeted Antigen Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Mitsubishi Chemical Advanced Materials
         18.1. Company Overview
         18.2. Targeted Antigen Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Polyone
         19.1. Company Overview
         19.2. Targeted Antigen Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Röchling
         20.1. Company Overview
         20.2. Targeted Antigen Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Rtp Company
         21.1. Company Overview
         21.2. Targeted Antigen Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Saint Gobain Performance Plastics
         22.1. Company Overview
         22.2. Targeted Antigen Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. Tekni Plex
         23.1. Company Overview
         23.2. Targeted Antigen Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24. Teknor Apex
         24.1. Company Overview
         24.2. Targeted Antigen Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25. Wacker Chemie
         25.1. Company Overview
         25.2. Targeted Antigen Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients